Calithera Biosciences Alpha and Beta Analysis
| CALADelisted Stock | USD 0.05 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Calithera Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Calithera Biosciences over a specified time horizon. Remember, high Calithera Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Calithera Biosciences' market risk premium analysis include:
Beta 2.25 | Alpha 12.61 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Calithera |
Calithera Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Calithera Biosciences market risk premium is the additional return an investor will receive from holding Calithera Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Calithera Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Calithera Biosciences' performance over market.| α | 12.61 | β | 2.25 |
Calithera Biosciences Fundamentals Vs Peers
Comparing Calithera Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Calithera Biosciences' direct or indirect competition across all of the common fundamentals between Calithera Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Calithera Biosciences or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Calithera Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Calithera Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Calithera Biosciences to competition |
| Fundamentals | Calithera Biosciences | Peer Average |
| Return On Equity | -1.14 | -0.31 |
| Return On Asset | -0.56 | -0.14 |
| Current Valuation | (1.1 M) | 16.62 B |
| Shares Outstanding | 4.87 M | 571.82 M |
| Shares Owned By Insiders | 1.07 % | 10.09 % |
| Shares Owned By Institutions | 26.76 % | 39.21 % |
| Number Of Shares Shorted | 417.28 K | 4.71 M |
Calithera Biosciences Opportunities
Calithera Biosciences Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Calithera Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Calithera or other pink sheets. Alpha measures the amount that position in Calithera Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Calithera Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Calithera Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Calithera Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Calithera Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Calithera Biosciences. Please utilize our Beneish M Score to check the likelihood of Calithera Biosciences' management manipulating its earnings.
| 27th of November 2023 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View |
Build Portfolio with Calithera Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Calithera Pink Sheet
If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |